Ana Silva - Concepedia

Author

Ana Silva

Also Known As

A. M. Silva, A. Martins Da Silva, A. Martins da Silva, A. Martins-Silva, A. Martins-da-Silva, A.M. Silva, ANA CESARINA FERREIRA DA SILVA, ANA GLEICY SALUSTINO DA SILVA, ANA LUIZA MARTINS GOMES SILVA, ANA LUÍSA APARECIDA DA SILVA

225

Publications

7.3K

Citations

H-Index

142

Concepts

All Affiliations

Centro Hospitalar do Porto Hospital de Santo António Universidade do Porto National Institute of Health Dr. Ricardo Jorge University of Oxford

About

Ana Silva is an author at Centro Hospitalar do Porto specializing in medicine, neurology, and multiple sclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	30	2.2K
2	Public Health	8	8	184
3	Health Sciences	2	2	913
4	Social Sciences	2	2	43
5	Arts	1	1	11

Ana Silva

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis Teresa Coelho, David Adams, Ana Silva, New England Journal of Medicine	2013	947
Multiple Sclerosis Severity Score Richard Roxburgh, Shaun R. Seaman, Thomas Masterman, Neurology	2005	945
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study Ludwig Kappos, Amit Bar‐Or, Bruce Cree, The Lancet Neurological DisorderClinical NeurologyClinical TrialsSiponimod Versus PlaceboNeurological Monitoring	2018	896
Tafamidis for transthyretin familial amyloid polyneuropathy Teresa Coelho, Luı́s F. Maia, Ana Silva, Neurology	2012	774
Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy Teresa Coelho, Luı́s F. Maia, Ana Silva, Journal of Neurology Alzheimer's DiseaseLong-term EffectsDisease ProgressionTtr StabilizationSymptomatic Treatment	2013	333
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial Gil I. Wolfe, Henry J. Kaminski, Inmaculada Aban, The Lancet Neurology	2019	216
Myasthenia gravis and neuromyelitis optica spectrum disorder Maria Isabel Leite, Estér Coutinho, Marco Aurélio Lana–Peixoto, Neurology	2012	202
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study David Adams, Michael Polydefkis, Alejandra González‐Duarte, The Lancet Neurology Alzheimer's DiseaseOpen-label Extension StudyMedicineHereditary Transthyretin-mediated AmyloidosisNeurology	2020	154
Influence of pregnancy on neuromyelitis optica spectrum disorder Woorim Kim, Sung Hoon Kim, Ichiro Nakashima, Neurology	2012	118
Pregnancy outcomes in aquaporin-4–positive neuromyelitis optica spectrum disorder Matthew M. Nour, Ichiro Nakashima, Estér Coutinho, Neurology	2015	116

Page 1